{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:19:19Z","timestamp":1770434359165,"version":"3.49.0"},"reference-count":71,"publisher":"Informa UK Limited","issue":"5-6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.3109\/10428199709055583","type":"journal-article","created":{"date-parts":[[2007,11,18]],"date-time":"2007-11-18T20:35:37Z","timestamp":1195418137000},"page":"449-461","source":"Crossref","is-referenced-by-count":14,"title":["CDKN2 (MTS1\/p16\n                    <sup>INK4A<\/sup>\n                    ) Gene Alterations in Hematological Malignancies"],"prefix":"10.1080","volume":"24","author":[{"given":"Toshiki","family":"Uchida","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Saito","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomitsu","family":"Hotta","sequence":"additional","affiliation":[{"name":"The Fourth Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"11","volume-title":"Clinical Oncology","author":"Fearon E. R","year":"1995","unstructured":"Fearon E. R. Oncogenes and tumor suppressor genes. Clinical Oncology, M. D. Abeloff, J. O. Armitage, A. S. Lichter, J. E. Niederhuber. Churchill Livingstone, New York 1995; 11\u201340"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8153634"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/368753a0"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.3.841.841"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.9.10.1149"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/366701a0"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90572-X"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.9.6.639"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/366704a0"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/371257a0"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.8.24.2939"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.5.2672"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.14.3.2077-2086.1994"},{"key":"e_1_2_1_15_1","first-page":"1581","article-title":"Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins","volume":"11","author":"Hall M.","year":"1995","unstructured":"Hall M., Bates S., Peters G. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 1995; 11: 1581\u20131588","journal-title":"Oncogene"},{"key":"e_1_2_1_16_1","first-page":"5816","article-title":"Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16INK4","volume":"54","author":"Tam S. W.","year":"1994","unstructured":"Tam S. W., Shay J. W., Pagano M. Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16INK4. Cancer Res. 1994; 54: 5816\u20135820","journal-title":"Cancer Res."},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90214-7"},{"key":"e_1_2_1_18_1","first-page":"2988","article-title":"Complex structure and regulation of p16 (MTS1) locus","volume":"55","author":"Stone S.","year":"1995","unstructured":"Stone S., Jiang P., Dayananth P., Tavtigen S. V., Katcher H., Parry D., Peters G., Kamb A. Complex structure and regulation of p16 (MTS1) locus. Cancer Res. 1995; 55: 2988\u20132994","journal-title":"Cancer Res."},{"key":"e_1_2_1_19_1","first-page":"2995","article-title":"A novel p16INK4A transcript","volume":"55","author":"Mao L.","year":"1995","unstructured":"Mao L., Merlo A., Bedi G., Shapiro G. I., Edwards C. D., Rollins B. J., Sidransky D. A novel p16INK4A transcript. Cancer Res. 1995; 55: 2995\u20132997","journal-title":"Cancer Res."},{"key":"e_1_2_1_20_1","first-page":"103","article-title":"Adenovirus-mediated p16\/CDKN2 gene transfer induces growth arrest and modifies transformed phenotype of glioma cells","volume":"12","author":"Fueyo J.","year":"1996","unstructured":"Fueyo J., Gomez-Manzano C., Alfred Tung W. K., Clayman G. L., Liu T. J., Bruner J., Levin V. A., Kyritsis A. P. Adenovirus-mediated p16\/CDKN2 gene transfer induces growth arrest and modifies transformed phenotype of glioma cells. Oncogene 1996; 12: 103\u2013110","journal-title":"Oncogene"},{"key":"e_1_2_1_21_1","first-page":"3250","article-title":"Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector","volume":"55","author":"Jin X.","year":"1995","unstructured":"Jin X., Nguyen D., Zhang W. W., Kyritsis A. P., Roth J. A. Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. Cancer Res. 1995; 55: 3250\u20133253","journal-title":"Cancer Res."},{"key":"e_1_2_1_22_1","first-page":"1448","article-title":"Mutations in the p16INK4\/MTS1\/CDKN2, p15INK4B\/MTS2, and p18 genes in primary and metastatic lung cancer","volume":"55","author":"Okamoto A.","year":"1995","unstructured":"Okamoto A., Hussain S. P., Hagiwara K., Spillare E. A., Rusin M. R., Demetrick D. J., Serrano M., Hannon G. J., Shiseki M., Zariwala M., Xiong Y., Beach D. H., Yokota J., Harris C. C. Mutations in the p16INK4\/MTS1\/CDKN2, p15INK4B\/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res. 1995; 55: 1448\u20131451","journal-title":"Cancer Res."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.2.755.bloodjournal862755"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05259.x"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.11.3781.bloodjournal84113781"},{"key":"e_1_2_1_26_1","first-page":"1211","article-title":"p27Kip1: Chromosomal mapping to 12p21-12p13.1 and absence of mutations in human tumors","volume":"55","author":"Ponce-Casta\u00f1eda M. V.","year":"1995","unstructured":"Ponce-Casta\u00f1eda M. V., Lee M. H., Latres E., Polyak K., Lacombe L., Montgomery K., Mathew S., Krauter K., Sheinfeld J., Massague J., Cordon-Cardo C. p27Kip1: Chromosomal mapping to 12p21-12p13.1 and absence of mutations in human tumors. Cancer Res. 1995; 55: 1211\u20131214","journal-title":"Cancer Res."},{"key":"e_1_2_1_27_1","first-page":"3375","article-title":"Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB","volume":"9","author":"Otterson G. A.","year":"1994","unstructured":"Otterson G. A., Kratzke R. A., Coxon A., Kim Y. W., Kaye F. J. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 1994; 9: 3375\u20133378","journal-title":"Oncogene"},{"key":"e_1_2_1_28_1","first-page":"6321","article-title":"CDKN2 (p16\/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas","volume":"54","author":"Schmidt E. E.","year":"1994","unstructured":"Schmidt E. E., Ichimura K., Reifenberger G., Collins V. P. CDKN2 (p16\/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res. 1994; 54: 6321\u20136324","journal-title":"Cancer Res."},{"key":"e_1_2_1_29_1","first-page":"4818","article-title":"Oncogenic aberrations of p16INK4\/CDKN2 and cyclin D1 cooperate to deregulate G1 control","volume":"55","author":"Lukas J.","year":"1995","unstructured":"Lukas J., Aagaard L., Strauss M., Bartek J. Oncogenic aberrations of p16INK4\/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res. 1995; 55: 4818\u20134823","journal-title":"Cancer Res."},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0994-15"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510123331504"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0994-27"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0196-97"},{"key":"e_1_2_1_34_1","first-page":"2713","article-title":"Loss of expression of the p16\/cyclin-dependent kinase inhibitor 2: tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression","volume":"55","author":"Reed J. A.","year":"1995","unstructured":"Reed J. A., Loganzo F. J., Shea C. R., Walker G. J., Flores J. F., Glendening J. M., Bogdany J. K., Shiel M. J., Haluska F. G., Fountain J. W., Albino A. P. Loss of expression of the p16\/cyclin-dependent kinase inhibitor 2: tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 1995; 55: 2713\u20132718","journal-title":"Cancer Res."},{"key":"e_1_2_1_35_1","first-page":"1941","article-title":"Loss of p16INK4 expression is frequent in high grade gliomas","volume":"55","author":"Nishikawa R.","year":"1995","unstructured":"Nishikawa R., Furnari F. B., Lin H., Arap W., Berger M. S., Cavenee W. K., Su Huang H. J. Loss of p16INK4 expression is frequent in high grade gliomas. Cancer Res. 1995; 55: 1941\u20131945","journal-title":"Cancer Res."},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.2763"},{"key":"e_1_2_1_37_1","first-page":"5531","article-title":"Homozygous loss of the p15INK4B gene (and not the p16INK4A gene) during tumor progression in sporadic melanoma patient","volume":"55","author":"Glendening J. M.","year":"1995","unstructured":"Glendening J. M., Flores J. F., Walker G. J., Stone S., Albino A. P., Fountain J. W. Homozygous loss of the p15INK4B gene (and not the p16INK4A gene) during tumor progression in sporadic melanoma patient. Cancer Res. 1995; 55: 5531\u20135535","journal-title":"Cancer Res."},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.4.1657.bloodjournal8741657"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1659741"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/329219a0"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.12.5116"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.4.1548.bloodjournal8641548"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1095-210"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0795-686"},{"key":"e_1_2_1_45_1","first-page":"4525","article-title":"Inactivation of the CDKN2\/p16\/MTS1 gene is frequently associated with aberrant DNA methylation in all common cancers","volume":"55","author":"Herman J. G.","year":"1995","unstructured":"Herman J. G., Merlo A., Mao L., Lapidus R. G., Issa J. P. J., Davidson N. E., Sidransky D., Baylin S. B. Inactivation of the CDKN2\/p16\/MTS1 gene is frequently associated with aberrant DNA methylation in all common cancers. Cancer Res. 1995; 55: 4525\u20134530","journal-title":"Cancer Res."},{"key":"e_1_2_1_46_1","first-page":"3396","article-title":"Frequent somatic mutation of the MTS1\/CDK4I (Multiple Tumor Suppressor\/Cylin-dependent Kinase 4 Inhibitor) gene in esophageal squamous cell carcinoma","volume":"54","author":"Mori T.","year":"1994","unstructured":"Mori T., Miura K., Aoki T., Nishihara T., Mori S., Nakamura Y. Frequent somatic mutation of the MTS1\/CDK4I (Multiple Tumor Suppressor\/Cylin-dependent Kinase 4 Inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 1994; 54: 3396\u20133397","journal-title":"Cancer Res."},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-114"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198508013130503"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.9.2321.bloodjournal8592321"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.6.2180.bloodjournal8762180"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.3.657.bloodjournal853657"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.4.1269.bloodjournal8641269"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.10.2685.bloodjournal85102685"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.7.2724.2724"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.4.893.bloodjournal854893"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.8.2900.2900"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.8.2412.2412"},{"key":"e_1_2_1_58_1","first-page":"2039","article-title":"p16 gene alterations in nasopharyngeal carcinoma","volume":"55","author":"Lo K. W.","year":"1995","unstructured":"Lo K. W., Huang D. P., Lau K. M. p16 gene alterations in nasopharyngeal carcinoma. Cancer Res. 1995; 55: 2039\u20132043","journal-title":"Cancer Res."},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.10.3619.bloodjournal86103619"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V65.3.649.649"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.10.2699.bloodjournal85102699"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.8.2013.bloodjournal8582013"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05358.x"},{"key":"e_1_2_1_64_1","first-page":"1436","article-title":"Involvement of CDKN2 (p16INK4A\/MTS1) and p15INK4B\/MTS2 in human leukemias and lymphomas","volume":"55","author":"Otsuki T.","year":"1995","unstructured":"Otsuki T., Clark H. M., Wellmann A., Jaffe E. S., Raffeld M. Involvement of CDKN2 (p16INK4A\/MTS1) and p15INK4B\/MTS2 in human leukemias and lymphomas. Cancer Res. 1995; 55: 1436\u20131440","journal-title":"Cancer Res."},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.1.311.bloodjournal861311"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/mc.2940140302"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8023167"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5247.350"},{"key":"e_1_2_1_69_1","first-page":"395","article-title":"Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene","volume":"57","author":"Puig S.","unstructured":"Puig S., Ruiz A., Lazaro C., Castel T., Lynch M., Palou J., Vilalta A., Weissenbach J., Mascaro M. J., Estivill X. Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene. Am. J. Hum. Genet., 57: 395\u2013402","journal-title":"Am. J. Hum. Genet."},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/370183a0"},{"key":"e_1_2_1_71_1","first-page":"63","article-title":"Mutations of p16 gene in gliomas","volume":"12","author":"Kyritsis A. P.","year":"1996","unstructured":"Kyritsis A. P., Zhang B., Zhang W., Xiao M., Takeshima H., Bondy M. L., Cunningham J. E., Levin V. A., Bruner J. Mutations of p16 gene in gliomas. Oncogene 1996; 12: 63\u201367","journal-title":"Oncogene"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.24.1870"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428199709055583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:10:28Z","timestamp":1770369028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428199709055583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":71,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["10.3109\/10428199709055583"],"URL":"https:\/\/doi.org\/10.3109\/10428199709055583","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}